Biofilm-specific antibiotic resistance
- PMID: 22953707
- DOI: 10.2217/fmb.12.76
Biofilm-specific antibiotic resistance
Abstract
Bacterial biofilms are the basis of many persistent diseases. The persistence of these infections is primarily attributed to the increased antibiotic resistance exhibited by the cells within the biofilms. This resistance is multifactorial; there are multiple mechanisms of resistance that act together in order to provide an increased overall level of resistance to the biofilm. These mechanisms are based on the function of wild-type genes and are not the result of mutations. This article reviews the known mechanisms of resistance, including the ability of the biofilm matrix to prevent antibiotics from reaching the cells and the function of individual genes that are preferentially expressed in biofilms. Evidence suggests that these mechanisms have been developed as a general stress response of biofilms that enables the cells in the biofilm to respond to all of the changes in the environment that they may encounter.
Similar articles
-
A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance.Nature. 2003 Nov 20;426(6964):306-10. doi: 10.1038/nature02122. Nature. 2003. PMID: 14628055
-
Densely adherent growth mode, rather than extracellular polymer substance matrix build-up ability, contributes to high resistance of Staphylococcus epidermidis biofilms to antibiotics.J Antimicrob Chemother. 2010 Jul;65(7):1405-11. doi: 10.1093/jac/dkq119. Epub 2010 Apr 29. J Antimicrob Chemother. 2010. PMID: 20430788
-
Oral biofilms: a reservoir of transferable, bacterial, antimicrobial resistance.Expert Rev Anti Infect Ther. 2010 Dec;8(12):1441-50. doi: 10.1586/eri.10.106. Expert Rev Anti Infect Ther. 2010. PMID: 21133668 Review.
-
Aminoglycoside antibiotics induce bacterial biofilm formation.Nature. 2005 Aug 25;436(7054):1171-5. doi: 10.1038/nature03912. Nature. 2005. PMID: 16121184
-
Biofilms in vitro and in vivo: do singular mechanisms imply cross-resistance?J Appl Microbiol. 2002;92 Suppl:98S-110S. J Appl Microbiol. 2002. PMID: 12000619 Review.
Cited by
-
Promising Therapeutic Strategies Against Microbial Biofilm Challenges.Front Cell Infect Microbiol. 2020 Jul 28;10:359. doi: 10.3389/fcimb.2020.00359. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 32850471 Free PMC article. Review.
-
Subinhibitory Concentrations of Allicin Decrease Uropathogenic Escherichia coli (UPEC) Biofilm Formation, Adhesion Ability, and Swimming Motility.Int J Mol Sci. 2016 Jun 29;17(7):979. doi: 10.3390/ijms17070979. Int J Mol Sci. 2016. PMID: 27367677 Free PMC article.
-
A ruthenium single atom nanozyme-based antibiotic for the treatment of otitis media caused by Staphylococcus aureus.Front Chem. 2024 Aug 28;12:1439039. doi: 10.3389/fchem.2024.1439039. eCollection 2024. Front Chem. 2024. PMID: 39263587 Free PMC article.
-
Comparative Assessment of Bacteriophage and Antibiotic Activity against Multidrug-Resistant Staphylococcus aureus Biofilms.Int J Mol Sci. 2022 Jan 24;23(3):1274. doi: 10.3390/ijms23031274. Int J Mol Sci. 2022. PMID: 35163197 Free PMC article.
-
Crumbling the Castle: Targeting DNABII Proteins for Collapsing Bacterial Biofilms as a Therapeutic Approach to Treat Disease and Combat Antimicrobial Resistance.Antibiotics (Basel). 2022 Jan 14;11(1):104. doi: 10.3390/antibiotics11010104. Antibiotics (Basel). 2022. PMID: 35052981 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical